非对比MRI斑块形态预测膝下闭塞导丝通过失败
本研究在截肢肢体模型中对27例慢性肢体威胁性缺血患者的46处膝下动脉病变行3T非对比MRI,将病变分为硬斑块(>50%钙化/胶原)与软斑块(<50%)。硬斑块导丝通过失败率显著高于软斑块(91% vs 8%,P < .001),提示该MRI协议可预测通过失败并辅助术前规划。
要点
- 非对比MRI定义的硬斑块(>50%钙化/胶原)与导丝通过失败显著相关。
- TASC C/D病变通过失败率显著高于TASC A/B(77% vs 33%)。
- 硬斑块中钙化程度高低不影响通过失败率,致密胶原可能独立起作用。
核心结论
- 超短回波时间/稳态自由进动非对比MRI可识别预测导丝通过失败的关键斑块成分,包括常规影像不可见的致密胶原。
研究设计与样本
- 在截肢肢体模型中对27例慢性肢体威胁性缺血患者的46处膝下动脉病变行3T非对比MRI,随后经皮血管介入尝试通过每处病变。
主要发现
- 硬斑块导丝通过失败率为91%,软斑块为8%(P < .001)。
- TASC C/D病变通过失败率为77%,TASC A/B为33%(P = .039)。
- GLASS III/IV病变通过失败率为73%,GLASS I/II为44%(P = .129),无统计学意义。
- 硬斑块中轻微钙化与显著钙化病变通过失败率分别为92%与90%(P > .99)。
- 闭塞与狭窄病变通过失败率分别为67%与80%(P = .70)。
关键数值与推荐
- 病变狭窄>75%或闭塞纳入评估,硬斑块定义为>50%钙化/胶原,软斑块为<50%。
- 硬斑块进一步分为轻微钙化硬斑块(<50%钙)与显著钙化硬斑块(>50%钙)。
- 病变同时采用TASC II与GLASS系统评分。
临床怎么用
- 该MRI协议可用于术前识别导丝通过失败高风险病变,辅助选择先进通过器械或旁路手术。
局限性
- 研究基于截肢肢体模型,样本量为27例患者46处病变,结论需在体临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The endovascular treatment of peripheral artery disease in the below knee arteries has high rates of immediate technical failure, most commonly owing to an inability to cross the lesion with a guidewire. Noncontrast magnetic resonance imaging (MRI) is able to characterize plaque composition and may identify patients at high risk for failed endovascular crossing. This study evaluates a novel noncontrast MRI protocol in an amputated limb model to identify impenetrable plaques, offering clinicians a tool for improved patient selection and procedural planning. METHODS: Patients with chronic limb-threatening ischemia undergoing major limb amputation were included and underwent 3T noncontrast MRI. Lesions with >75% stenosis or occlusion in the below the knee arteries were evaluated and defined as either hard (>50% calcium/collagen) or soft (<50%). Hard lesions were then further delineated into two groups: minimally calcific hard (<50% calcium) and significantly calcific hard lesions (>50% calcium). Lesions were also scored using Trans-Atlantic Inter-Society Consensus Score (TASC) II and Global Limb Anatomic Severity Score (GLASS) systems. Amputated limbs then underwent percutaneous vascular intervention to cross each lesion. The primary end point was to compare crossing success in MRI-defined hard vs soft lesions. Secondary outcomes included comparing TASC C/D with TASC A/B lesions, GLASS III/IV and I/II lesions, ability to cross in minimally vs significantly calcified hard lesions, and stenotic vs total occlusions. RESULTS: The study included 27 patients with 46 arterial lesions. Twelve (26%) lesions were defined as soft and 34 (74%) were hard. MRI plaque characteristics demonstrated a strong predictive value: hard lesions were significantly less likely to be crossable compared with soft lesions (91% vs 8%; P < .001). TASC C/D lesions had significantly higher crossing failure rates compared with TASC A/B lesions (77% vs 33%; P = .039), whereas GLASS III/IV lesions did not achieve statistical significance when compared with GLASS I/II lesions (73% vs 44%; P = .129). Among hard lesions, there was no significant difference in ability to cross between minimally calcific and significantly calcific lesions (92% vs 90%; P > .99). There was also no significant difference in the ability to cross occluded vs stenotic lesions (67% vs 80%; P = .70). CONCLUSIONS: Ultrashort echo timeUTE)/steady-state free precession (SSFP) noncontrast MRI identifies critical plaque components that predict crossing failure, including dense collagen, which is not visible on conventional imaging yet appears to play a critical role in crossing failure that is independent of calcium burden. This MRI protocol could transform decision-making. Its implementation in clinical practice offers an evidence-based approach that could potentially decrease endovascular failures, ensure advanced crossing devices are available for complex lesions, and guide treatment choices for bypass surgery vs endovascular treatment.
引用
- Crichton AB, Csore J, Pomozi E, et al. Clinical magnetic resonance imaging-defined plaque morphology predicts guidewire crossing failure in below-the-knee occlusions in a translational model using amputated lower limbs. J Vasc Surg. 2025. PMID: 41167379. doi:10.1016/j.jvs.2025.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。